Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California. Show more
Location: 701 Anacapa Street, Santa Barbara, CA, 93101, United States | Website: https://phytanix.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
2.901M
52 Wk Range
$2.25 - $15.26
Previous Close
$3.34
Open
$3.38
Volume
47,966
Day Range
$3.34 - $3.47
Enterprise Value
-1.952M
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
11.21%
Institutional Own.
10.11%
Qtr Updated
03/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PT00114 Details Addiction, Post-traumatic stress disorder, Treatment Resistant Depression, Social Anxiety Disorder | Phase 1/2 Data readout |